Field strength dependence of grey matter R2* on venous oxygenation by Croal, Paula L. et al.
Croal, Paula L. and Driver, Ian D. and Francis, Susan T. 
and Gowland, Penny A. (2016) Field strength 
dependence of grey matter R2* on venous oxygenation. 
NeuroImage . ISSN 1095-9572 
Access from the University of Nottingham repository: 
http://eprints.nottingham.ac.uk/37609/1/1-s2%200-S1053811916305523-main.pdf
Copyright and reuse: 
The Nottingham ePrints service makes this work by researchers of the University of 
Nottingham available open access under the following conditions.
This article is made available under the Creative Commons Attribution licence and may be 
reused according to the conditions of the licence.  For more details see: 
http://creativecommons.org/licenses/by/2.5/
A note on versions: 
The version presented here may differ from the published version or from the version of 
record. If you wish to cite this item you are advised to consult the publisher’s version. Please 
see the repository url above for details on accessing the published version and note that 
access may require a subscription.
For more information, please contact eprints@nottingham.ac.uk
Author’s Accepted Manuscript
Field strength dependence of grey matter R2* on
venous oxygenation
Paula L. Croal, Ian D. Driver, Susan T. Francis,
Penny A. Gowland
PII: S1053-8119(16)30552-3
DOI: http://dx.doi.org/10.1016/j.neuroimage.2016.10.004
Reference: YNIMG13501
To appear in: NeuroImage
Received date: 12 April 2016
Revised date: 19 September 2016
Accepted date: 1 October 2016
Cite this article as: Paula L. Croal, Ian D. Driver, Susan T. Francis and Penny A.
Gowland, Field strength dependence of grey matter R2* on venous oxygenation,
NeuroImage, http://dx.doi.org/10.1016/j.neuroimage.2016.10.004
This is a PDF file of an unedited manuscript that has been accepted for
publication. As a service to our customers we are providing this early version of
the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting galley proof before it is published in its final citable form.
Please note that during the production process errors may be discovered which
could affect the content, and all legal disclaimers that apply to the journal pertain.
www.elsevier.com
1 
 
Field strength dependence of grey matter R2
* on venous oxygenation 
Paula L. Croal1, Ian D. Driver1, Susan T. Francis1, Penny A. Gowland1* 
 
Sir Peter Mansfield Imaging Centre, School of Physics and Astronomy, University of 
Nottingham, UK. 
 
*Corresponding Author: Sir Peter Mansfield Imaging Centre, School of Physics and 
Astronomy, University of Nottingham, Nottingham, NG7 2RD, Tel: 0115 9514747. 
Email: penny.gowland@nottingham.ac.uk 
 
 
 
 
Abstract 
 
The relationship between venous blood oxygenation and change in transverse 
relaxation rate (ΔR2
*) plays a key role in calibrated BOLD fMRI. This relationship, 
defined by the parameter β, has previously been determined using theoretical 
simulations and experimental measures. However, these earlier studies have been 
confounded by the change in venous cerebral blood volume (CBV) in response to 
functional tasks. This study used a double-echo gradient echo EPI scheme in 
conjunction with a graded isocapnic hyperoxic sequence to assess quantitatively the 
relationship between the fractional venous blood oxygenation (1-Yv) and transverse 
relaxation rate of grey matter (ΔR2
*
GM), without inducing a change in vCBV.  
 
The results demonstrate that the relationship between ΔR2
* and fractional venous 
oxygenation at all magnet field strengths studied was adequately described by a linear 
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relationship. The gradient of this relationship did not increase monotonically with field 
strength, which may be attributed to the relative contributions of intravascular and 
extravascular signals which will vary with both field strength and blood oxygenation.  
 
Key words: calibrated BOLD, fMRI, R2
* quantification, oxygenation, hyperoxia.  
 
 
 
 
 
 
 
1. Introduction 
 
The blood oxygenation level dependent (BOLD) signal arises from the interplay 
between cerebral blood flow (CBF) and the cerebral metabolic rate of oxygen (CMRO2) 
consumption. However, the magnitude of the BOLD signal also depends on baseline 
physiological parameters such as cerebral blood volume (CBV), oxygen extraction 
fraction (OEF) and haematocrit (Hct) (Kim et al., 2012; Levin et al., 2001; Lin et al., 
1998). These parameters can vary for a given individual across repeated scan sessions, 
between healthy subjects, and in particular across patient groups. This results in 
variability in the magnitude of the BOLD signal, which can be minimised by using the 
calibrated BOLD signal to measure changes in the CMRO2 non-invasively. The original 
calibrated BOLD model of Davis et al. (1998) provides a non-invasive method to 
quantify the fractional change in cerebral metabolic rate of oxygen (CMRO2) by using 
the vasodilatory effect of hypercapnia to normalise the BOLD signal.  
 
Current models of calibrated BOLD depend on the relationship between the apparent 
transverse relaxation rate (R2
*) and concentration of deoxyhaemoglobin (dHb) in the 
blood, or fractional venous oxygenation (1-Yv) (Ogawa et al., 1993). The contribution to 
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R2
* from deoxygenated blood (ΔR2
*) can be described as a function of venous CBV 
(vCBV) and blood concentration of dHb,  
 
   
       [   ]     Equation 1 
 
where [dHb] is a function of OEF and Hct (Davis et al., 1998), and k is a constant 
incorporating properties such as vessel geometry, magnet field strength (B0) and blood-
tissue susceptibility differences.   
  
The parameter β has traditionally been predicted from Monte Carlo simulations and 
analytical models (Boxerman et al., 1995; He et al., 2007; Ogawa et al., 1993; 
Yablonskiy et al., 1994). This involves modelling the microscopic magnetic field 
gradients between deoxygenated blood vessels and the surrounding diamagnetic tissue 
to estimate the resulting enhancement of the R2
* decay rate. For the extravascular (EV) 
compartment, the result depends on whether the system is in the static dephasing 
regime (larger vessels, β → 1) or the diffusive dephasing regime (smaller vessels, β → 
2). The vessel size limit where the transition between these regimes occurs reduces as 
B0  increases (Kennan et al., 1994), such that Monte Carlo simulations predict the 
widely accepted value of β  = 1.5 for a vascular network at 1.5 T, and β = 1 at 7 T 
(Boxerman et al., 1995; Ogawa et al., 1993; Yablonskiy et al., 1994). However, the 
reliability of these results depends on how realistic the model is. In particular, models 
should also consider the effect of changes in intravascular (IV) signal contributions due 
to concomitant changes in vCBV, for example due to vessel dilation in response to 
functional activation or hypercapnia, and vessel constriction in response to non-
isocapnic hyperoxia. This IV contribution can be significant as the R2
* of blood increases 
quadratically with increasing deoxygenation (Blockley et al., 2012; Li et al., 1998). At 
fields below 3 T the intravascular signal from the veins represents a significant fraction 
of the BOLD signal, estimated to be approximately 57 % at 1.5 T, 36 % at 3 T, and 
negligible at 7 T (Uludag et al., 2009; van der Zwaag et al., 2009), depending on echo 
time. 
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More recently, experimental measurements of β have been published (Driver et al., 
2010; Rossi et al., 2012; van der Zwaag et al., 2009; Wise et al., 2013), which are in 
reasonable agreement with model-based predictions. However, while theoretical 
estimates may not fully account for intravascular (IV) signal contributions, experimental 
measurements to date have been subject to potential concomitant changes in vCBV, 
arising from vessel dilation in response to functional activation or hypercapnia, or vessel 
constriction in response to non-isocapnic hyperoxia.  
 
This study aims to measure the relationship between fractional change in concentration 
of deoxyhaemoglobin in venous blood and grey matter R2
*, without a confounding 
change in vCBV, using a dynamic isocapnic hyperoxic stimulus at 1.5, 3 and 7 T.  
 
 
 
1. Material and Methods 
 
The study was approved by the University of Nottingham Medical School Ethics 
Committee and all subjects gave prior informed written consent. Eight healthy 
volunteers (aged 24-27 years, 5 male) participated in the study. MR data was collected 
on Philips Achieva systems at three B0s, a 1.5 T system with 8-channel SENSE receive 
coil, a 3 T system with 32-channel SENSE receive coil and a 7 T system with head 
volume transmit and 32-channel SENSE receive coil. 
 
An isocapnic hyperoxic stimulus was delivered to subjects using a feed-forward, low gas 
flow system (RespirAct™, Thornhill Research Inc., Toronto, Canada) in which arterial 
blood gases were controlled by a prospective targeting system consisting of a 
computerized gas blender and sequential gas delivery breathing circuit. The system 
uses the method of Slessarev et al. (2007) to target end-tidal PCO2 (PETCO2) and 
PO2 (PETO2) independently of each other and independent of breathing pattern (Fierstra 
et al., 2013). Subjects received medical air via the RespirAct™ until the respiratory 
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challenge commenced. The respiratory paradigm consisted of three minutes of 
normocapnic (maintaining PETCO2 at resting levels) normoxia, followed by a 4 minute 
normocapnic linear increase in PETO2 to a maximum level of 500 mmHg (an 
approximate 8 mmHg increase in PETO2 with each breath), a linear decrease in PETO2 to 
return to baseline over 4 minutes while continuing to maintain normocapnia, and a final 
1 minute of normocapnic normoxia. The total respiratory paradigm was thus 12 minutes 
in duration. 
 
Double echo gradient echo EPI (GE-EPI) data were acquired throughout the respiratory 
paradigm. At all three magnet field strengths, five contiguous axial slices positioned 
superior to the ventricles were acquired, with an in-plane resolution of 2×2 mm3, 3 mm 
slice thickness, and field of view of 212×188×15 mm3, 212×184×15 mm3 and 
192×192×15 mm3 at 1.5, 3 and7 T respectively. Imaging parameters were TR of 3 s, 
SENSE factor 2.5, flip angle 90°, and TE1/TE2 of 25/80 ms, 22/60 ms and 16/47 ms at 
1.5, 3 and 7 T respectively. These double echo GE-EPI echo times were selected to 
optimally fit T2
* based on the expected grey matter T2
* value at each B0, as reported in 
Peters et al. (2007). In addition, at normoxia, a series of inversion recovery GE-EPI 
images were acquired at 10 inversion times (100, 200, 300, 500, 700, 1000, 1300, 
1500, 2100 and 2600 ms) with matched geometry to the double echo GE-EPI data, 
which were fit for longitudinal relaxation time, T1. The first echo (TE1) images of the 
double echo GE-EPI datasets were motion corrected using MCFLIRT (FSL, fMRIB, 
Oxford, UK) and the resulting transforms were applied to the second echo (TE2) 
images. A grey matter (GM) mask was formed by thresholding T1 maps at 1.0 ≤ T1 ≤ 
1.3 s, 1.45 ≤ T1 ≤ 1.75 s, and 1.8 ≤ T1 ≤ 2.1 s for 1.5, 3 and 7 T respectively. To 
remove any remaining contributions in the GM mask from cerebral spinal fluid (CSF) 
and large veins, those voxels with highest and lowest 3% of signal intensity respectively 
in the second echo (TE2) GE-EPI images were removed from the GM mask. R2
* maps 
were then calculated within the GM mask on a voxel-wise basis using 
  
  
  
 
       
  (
  
  
)                                             Equation 2 
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where S1 and S2 denote the signals measured at TE1 and TE2. The mean baseline R2
* 
was then estimated for the GM mask from the normoxic period, and the baseline R2
* 
subtracted from each R2
* value on hyperoxia, to obtain a timeseries of ΔR2
*
GM.  
 
The PETO2 trace was linearly interpolated to a TR of 3 s and PETO2 measurements were 
converted to venous oxygenation (Yv), assuming a baseline OEF of 0.4  (Chiarelli et al., 
2007). Yv values were binned across the full theoretical range of 0.6 to 0.7, in steps of 
0.025 to enable the corresponding R2
*
GM data to be group averaged over these bins. 
For each individual subjects’ data, at each B0, the average value of ΔR2
*
GM within the 
GM mask was fitted to two models. First, a simple linear function  
 
                                                          
   (    )                                         Equation 3 
 
where (1-Yv) is proportional to [dHb] in Equation 1, and A and C are the fitted gradient 
and intercept (which takes account of the fact that we do not measure ΔR2
*
GM with 
respect to Yv = 0). Second, to a power law function  
 
                                                     
    (    )
                                      Equation 4 
 
to estimate A’, β and C’, using a non-linear, three parameter least squares fit. Data were 
also fitted to Equation 4, fixing β to published B0-corrected values (1.5, 1.3 and 1 for 
1.5T, 3T and 7T respectively (Bulte et al., 2009; Davis et al., 1998; Driver et al., 2012)). 
The Chi-squared (Χ2) was used as a measure of the goodness of fit.  
 
We also simulated the relationship between the EV signal and venous oxygenation by 
using the known blood deoxyhaemoglobin relaxivity to separate the IV component from 
the total tissue signal, to explore contributions of any residual IV signal which was not 
accounted for by removal of voxels containing large vessels. While the intravascular 
relaxation rate R2
*
IV varies quadratically with (1-Yv) (Blockley et al., 2008; Li et al., 1998) 
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a linear relationship was assumed across the range of venous oxygenation targeted in 
this study (0.6-0.7) (Blockley et al., 2008). The resulting estimates of R2
*
IV were 
combined with the measured values of ΔR2*GM to estimate the variations in ΔR2*EV. First 
a simple two compartment model was assumed:    
 
                          EVIV RTEvRTEvvoxel efefMS
*
2
*
2 ..
0 ).1(.
                Equation 5 
 
where Svoxel is the GM signal measured from a voxel at echo time TE, ƒv is intravascular 
blood volume fraction (assumed to be 3% (Helenius et al., 2003; Lee et al., 2001)) and 
R2
*
IV and R2
*
EV correspond to the R2
* of the IV and EV compartments respectively, 
neglecting vessel orientation effects. The ratio of the signal measured at echo times TE1 
and TE2 can then be written as: 
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Assuming that ΔR2
*
EV also varied linearly with Y over the range of interest and a 
literature value of f, the variation in S1/S2 versus (1-Yv) was fitted to determine the 
expected values of ΔR2
*
EV. In this simulation the differences in T1 and spin density 
between tissue and blood were assumed negligible; in fact tissue possesses a slightly 
lower spin density and shorter T1 than blood so these effects will work in opposing 
directions.  
 
3. Results 
 
Average baseline and peak PETO2 values achieved at each B0 are shown in Table 1, 
along with the corresponding Yv value. Group averaged PETO2 traces are shown in 
Figure 1A-C. PETCO2 values were maintained within ± 0.39 mmHg of an individuals’ 
resting level, with the mean change between baseline normoxia and peak hyperoxia 
being 0.70 ± 0.12 mmHg, across all subjects and B0. Such fluctuations in PETCO2 were 
assumed to have minimal influence on R2
*. Baseline (normoxic) R2
*
GM increased 
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significantly with B0 (p < 0.005, Wilcoxon signed rank test). Example Yv and ΔR2
*
GM 
timecourses are shown for representative subjects across B0 in Figures 1D-F. 
Corresponding maps of R2
* and the gradient (A) of the linear fit to Equation 3 are 
depicted in Figure 2.   
 
 
 
Figure 1: A-C) Group averages of end tidal partial pressure of oxygen (PETO2) 
shown in black at each field strength across the twelve minute respiratory 
paradigm. Grey regions indicate standard deviation. D-F) Interpolated venous 
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oxygenation (Yv) time course for representative subjects and accompanying ΔR2
* 
(s-1) at B) 1.5 T, C) 3 T and D) 7 T.  
 
 
 
Figure 2: Grey matter (GM) masks, EPIs for TE1 and TE2 at normoxic baseline, 
with corresponding R2
* images, and voxelwise gradient of ΔR2
*
GM versus (1-Yv). 
Data shown for representative subjects at A) 1.5 T, B) 3 T and C) 7 T.  
 
Figure 3A shows the effect of the fractional change in venous oxygenation (1-Yv) on Δ
R2
*
GM for each B0. The average gradient, A, of the linear fit of ΔR2
*
GM versus (1-Yv) 
(Equation 3) is given in Table 1. This was significantly larger for 7 T than 1.5 or 3 T (p = 
0.043, Kruskall-Wallis one-way ANOVA), although no significant difference was 
observed between 1.5 and 3 T.   
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Figure 3: A) Effect of change in fractional venous oxygenation (1-Yv) on A) ΔR2
*
GM 
(s-1) and B) ΔR2
*
EV (s
-1), shown at 1.5 T (black), 3 T (grey) and 7 T (red). Data 
binned and averaged across subjects.  
 
The data was sufficiently described by the linear 2 parameter (A and C) model fit 
(Equation 3) (p < 0.01 in all cases). The 3 parameter model, showed no significant 
improvements in goodness-of-fit (Χ2 Difference test) when compared to either of the 2 
parameter fits (linear, and fixed B0-corrected values of β).  
 
When R2*EV was estimated across binned Yv values based on the measured signals 
and estimated R2*IV, the results demonstrated a monotonic increase in the gradient of 
ΔR2
*
EV and (1-Yv) with B0 (Figure 3B). Figure 4 illustrates subsequent intravascular and 
extravascular GM signal components for the echo times and field strengths used in this 
study, for both normoxia and hyperoxia, using Equation 5. 
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Figure 4: Variation in relative IV signal contribution with (1-Yv) estimated for each 
echo time and field strength.  
 
 
4. Discussion 
The relationship between ΔR2
*
GM and fractional venous oxygenation (1-Yv) was 
measured at 1.5, 3 and 7 T, and found to be well-described by a linear relationship at all 
B0s. This contrasts with previous studies which inferred that β ≥ 1 by manipulating B0 
(Driver et al., 2010; Rossi et al., 2012; van der Zwaag et al., 2009), and by the direct 
measurement of a value of β of 1.35 at 3 T using the response to combined hyperoxia 
and hypercapnia (Wise et al., 2013). In our study β was measured using an isocapnic 
hyperoxic stimulus and so the results are not confounded by changes in vCBV which 
will have occurred in previous studies, with vCBV altered by motor activation (van der 
Zwaag et al., 2009), the vasodilative effect of hypercapnia (Driver et al., 2010; Wise et 
al., 2013) or non-isocapnic hyperoxia (Rossi et al., 2012).  
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Baseline R2
*
GM increased monotonically and approximately linearly with B0, in 
agreement with published cross-field values (Rossi et al., 2012; van der Zwaag et al., 
2009). In contrast, the gradient of ΔR2
*
GM versus (1-Yv) measured in this study did not 
increase monotonically (Figure 3). Extravascular dephasing depends on the 
intravascular frequency shift (Δω), which depends linearly on both (1-Yv) and B0: 
 
          
)1.(..". 0 vYBk                 Equation 7 
 
where k” is a constant reflecting vessel geometry, γ is the gyromagnetic ratio and Δχ is 
the difference in magnetic susceptibility between fully deoxygenated blood and tissue. 
Therefore, if we were only sensitive to extravascular signal in the static or indeed 
diffusive regimes, the gradient of ΔR2
*
GM versus (1-Yv) would be expected to increase 
monotonically with B0 (Boxerman et al., 1995; Ogawa et al., 1993; Yablonskiy et al., 
1994). In practice, the gradient was effectively constant between 1.5 and 3 T and 
increased faster than linearly with B0 between 3 and 7 T (Table 1).  
 
In practice, the non-negligible intravascular (IV) signal will contribute to the signal from 
GM (Hare et al., 2016), even when signal from large vessels has been masked out, as 
was the case in this work. Therefore, the unexpected variation in the gradient of ΔR2
*
GM 
versus (1-Yv) with B0 might be explained by a variation in the ratio of IV signal to EV 
signal contributions with both B0 and echo time (TE). Here we combined measured 
values of ΔR2
*
GM with previously published values of R2
*
IV to estimate ΔR2
*
EV, and the 
results indicated that the gradient of ΔR2
*
EV versus (1-Yv) increased monotonically with 
B0 as expected (Boxerman et al., 1995; Ogawa et al., 1993; Yablonskiy et al., 1994).  
 
If a multi-compartment signal decay is fitted to a single exponential, the apparent R2
* will 
depend on the choice of echo times at which the signal is sampled. Figure 4 illustrates 
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how the estimated relative contribution of intravascular signal to total signal varies with 
oxygenation and field strength for the T2* values measured here. The IV signal is 
smaller at normoxia than at hyperoxia, and therefore contributes less to the total signal 
as (1-Yv) increases. Furthermore, for the echo times used here, the IV signal is more 
sensitive to changes in fractional venous oxygenation than the EV signal, particularly at 
lower field. This varying intravascaular signal contribution may explain the unexpected 
variation of the gradient of ΔR2
*
GM versus (1-Yv) with B0. However, it should also be 
noted that any trends in the gradient of a linear fit over a limited range of (1-Yv) could be 
hard to interpret if the underlying function was not in fact linear. Future studies designed 
specifically to explore these relationships should use a multi-echo EPI readout and 
vascular crushing to separate the different IV and EV compartments. In this study the 
frequency offset (Δω) between tissue and blood was varied by changing both venous 
oxygenation and B0. To fully characterise the dependency of grey matter R2
* on Δω, a 
larger intravascular susceptibility perturbation is required, either by modulating venous 
blood oxygenation over a wider range, which is difficult to achieve physiologically, or by 
using a paramagnetic contrast agent.  
 
In summary if the underlying physical value of β for any compartment is non-linear, then 
the effective value of β will depend on experimental parameters and local tissue 
microvasculature (Griffeth et al., 2011; Martindale et al., 2008), but for calibrated BOLD 
an additional experiment to determine β would be impractical. However for the 
experimental protocol used here, which was deliberately characteristic of standard fMRI 
experiments, a linear approximation was sufficient to describe the observed behaviour 
across the limited range of (1-Yv) = 0.3-0.4 relevant to the fMRI BOLD effect at all field 
strengths, which could simplify the calibration of the BOLD signal (Blockley et al., 2015; 
Griffeth et al., 2013; Merola et al., 2016). Recent work (Griffeth et al., 2011; Merola et 
al., 2016) has tested calibrated BOLD models by comparing the relatively simple BOLD 
signal models with a more detailed, multi-compartment BOLD signal model, treating this 
more detailed model as a gold standard from which to test the specificity of the 
calibrated BOLD approach to simulated data. The main conclusion of this work was that 
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the physical meaning of the parameter β (alongside a physiological CBV/CBF coupling 
parameter) should be relaxed and their values treated as free parameters.  
 
It has previously been shown that a strong hyperoxic stimulus (FiO2 = 1) will cause 
macroscopic alterations in inferior brain regions at 3T which can increase the measured 
R2*, although such effects were reduced under moderate hyperoxia (FiO2 = 0.5) 
(Pilkinton et al., 2011). Similarly at 7 T, we have previously observed whole-head field 
shifts under moderate hyperoxia (~FiO2 = 0.6, PETO2 = 500mmHg), although this only 
resulted in significant changes in R2
* in regions close to the frontal sinus (Driver et al., 
2011). In this work such macroscopic effects were mitigated by selecting slices superior 
to the ventricles, and using moderate hyperoxia. Nonetheless, further quantification of 
macroscopic inhomogeneities caused by hyperoxia and their impact on R2
* are required 
to enable whole-head analysis.  Furthermore, a different paradigm (e.g. sinusoidal 
(Blockley et al., 2010)) would make it easier to remove any drifts from the data.  
 
5. Conclusions 
 
This work presents the first experimental measurement of β in humans using an 
isocapnic hyperoxic stimulus to remove confounds associated with a change in CBV 
arising from functional activation or modulation of PETO2 during a respiratory challenge. 
It was also found that for the regimes relevant to calibrated BOLD experiments, a value 
of β=1 is a reasonable assumption, which may help simplify the calibrated BOLD model.   
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Table 1: Average baseline and peak PETO2 values and corresponding venous 
oxygenation (Yv) estimated according to the interpolation method outlined in 
Chiarelli et al. (2007).  Baseline R2
*
GM
 (s-1) and the gradients (A) of ΔR2
*
GM
 versus 
(1-Yv) for both β = 1 (linear model) and typical B0-adjusted values of β. Χ
2 depicts 
goodness-of-fit. Data (mean ± SEM) averaged across subjects for each magnet 
field strength (B0). † denotes p < 0.01. 
 PETO2 (mmHg) Venous 
oxygenation (Yv) 
MR parameters for GM mask 
B0  
(T) 
Baseline Peak Baseline Peak Baseline 
R2
*
GM
 
(s
-
1
) 
Gradient 
(A) of 
ΔR2
*
GM v. 
(1-Yv) 
linear fit 
(Equation 
3) 
(s
-1
) 
 
Χ2  for 
nonlinear fit 
using B0-
corrected β 
values 
(Equation 4)  
 
Χ2 for 
nonlinear 3 
parameter 
fit 
(Equation 
4)  
1.5 115 ± 3 482 ± 
11 
0.600 ± 
0.001 
0.670 
± 
0.002 
12.7 ± 
0.2  
4.1 ± 0.4 
(2 = 6.4 ± 
2.0
†
) 
  
2 = 6.4 ± 
2.0
†
 

2 = 6. 4 ± 
2.0
†
 
3 109 ± 3 485 ± 
9 
0.600 ± 
0.001 
0.680 
± 
0.001 
19.5 ± 
0.5 
3.9 ± 0.3 
(2 = 4.3 ± 
1.1
†
) 
  
2 = 4.3 ± 
1.1
†
 

2 = 4.2 ± 
1.8
†
 
7 119 ± 2 490 ± 
13 
0.600 ± 
0.001  
0.670 
± 
0.003 
33.2 ± 
0.7 
13.2 ± 2.0 
(2 = 4.7 ± 
1.8
†
) 
  
2 = 4.7  ± 
1.8
†
 

2 = 4.6 ± 
1.8
†
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Highlights 
 We assess the relationship between grey matter R2* and venous oxygenation 
 Isocapnic hyperoxia prevented confounding changes in cerebral blood volume 
 A linear dependency is an appropriate assumption at 1.5, 3 and 7 Tesla 
 Intravascular/extravascular signal ratios will vary with both B0 and oxygenation 
